$-0.01 EPS Expected for Bovie Medical (BVX); Profile of 9 Analysts Covering Brookfield Asset Management Inc. (BAM)

February 17, 2018 - By Darrin Black

Analysts expect Bovie Medical Corporation (NYSEAMERICAN:BVX) to report $-0.01 EPS on March, 8.They anticipate $0.03 EPS change or 75.00% from last quarter’s $-0.04 EPS. After having $-0.04 EPS previously, Bovie Medical Corporation’s analysts see -75.00% EPS growth. The stock increased 4.17% or $0.1 during the last trading session, reaching $2.5. About 45,185 shares traded. Bovie Medical Corporation (NYSEAMERICAN:BVX) has risen 28.74% since February 17, 2017 and is uptrending. It has outperformed by 12.04% the S&P500.

Among 9 analysts covering Brookfield Asset Management Inc. (NYSE:BAM), 9 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Brookfield Asset Management Inc. had 30 analyst reports since August 10, 2015 according to SRatingsIntel. The stock of Brookfield Asset Management Inc. (NYSE:BAM) has “Buy” rating given on Thursday, November 9 by RBC Capital Markets. The stock of Brookfield Asset Management Inc. (NYSE:BAM) earned “Sell” rating by Zacks on Monday, August 17. The firm has “Buy” rating by Keefe Bruyette & Woods given on Friday, November 10. The stock of Brookfield Asset Management Inc. (NYSE:BAM) earned “Buy” rating by RBC Capital Markets on Tuesday, July 25. The rating was maintained by Canaccord Genuity with “Buy” on Monday, October 2. Wood maintained it with “Buy” rating and $45 target in Monday, May 15 report. The rating was maintained by RBC Capital Markets on Monday, November 14 with “Top Pick”. RBC Capital Markets maintained the shares of BAM in report on Wednesday, November 1 with “Buy” rating. The firm has “Buy” rating given on Friday, August 11 by Canaccord Genuity. Citigroup maintained Brookfield Asset Management Inc. (NYSE:BAM) rating on Friday, November 10. Citigroup has “Buy” rating and $49.5 target. See Brookfield Asset Management Inc. (NYSE:BAM) latest ratings:

16/02/2018 Broker: Scotia Capital Rating: Buy New Target: $48.5 Maintain
09/11/2017 Broker: RBC Capital Markets Rating: Buy New Target: $45.0 Maintain
09/11/2017 Broker: TD Securities Rating: Buy New Target: $52.0 Maintain
10/11/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $47.0 Maintain
10/11/2017 Broker: Citigroup Rating: Buy Old Target: $50 New Target: $49.5 Maintain
01/11/2017 Broker: RBC Capital Markets Rating: Buy New Target: $43.0 Maintain
02/10/2017 Broker: Canaccord Genuity Rating: Buy New Target: $47.0 Maintain
29/09/2017 Broker: TD Securities Rating: Buy New Target: $65.00 Target Up
26/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $43.0 Maintain
25/09/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $45.0 Maintain

Bovie Medical Corporation, a medical device company, develops, makes, and markets electrosurgical devices and technologies, and related medical products used in doctor's offices, surgery centers, and hospitals worldwide. The company has market cap of $82.15 million. The firm provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It currently has negative earnings. It also offers electrosurgical disposables comprising Resistick II, a proprietary coating applied to stainless steel that resist eschar during surgery; and disposable laparoscopic electrodes for use by physicians in the areas of gynecology, general surgery, and urology.

Investors sentiment increased to 1.21 in Q3 2017. Its up 0.14, from 1.07 in 2017Q2. It increased, as 6 investors sold Bovie Medical Corporation shares while 8 reduced holdings. 11 funds opened positions while 6 raised stakes. 8.25 million shares or 5.67% more from 7.81 million shares in 2017Q2 were reported. Millrace Asset Group Inc Incorporated holds 1% or 315,000 shares. Northern Trust Corporation stated it has 79,399 shares. Blackrock Inc has 97,041 shares for 0% of their portfolio. Commercial Bank Of America Corporation De holds 0% of its portfolio in Bovie Medical Corporation (NYSEAMERICAN:BVX) for 1,571 shares. Emerald Mutual Fund Advisers Tru has 0.07% invested in Bovie Medical Corporation (NYSEAMERICAN:BVX) for 490,000 shares. Archon Management Lc has 75,076 shares. Wells Fargo Company Mn invested in 0% or 9,440 shares. Vanguard Group Incorporated holds 0% or 864,386 shares. Raymond James Financial Service Advsrs Inc reported 109,950 shares. Bank Of Montreal Can reported 1,500 shares. Barclays Plc holds 0% or 64 shares. Perkins Capital Mngmt accumulated 623,685 shares or 2.21% of the stock. Atria Invests Limited Liability Corporation reported 0% in Bovie Medical Corporation (NYSEAMERICAN:BVX). Dimensional Fund Advsr Ltd Partnership holds 0% or 183,827 shares in its portfolio. Moreover, Sei has 0% invested in Bovie Medical Corporation (NYSEAMERICAN:BVX).

The stock increased 1.69% or $0.67 during the last trading session, reaching $40.28. About 1.59M shares traded or 38.16% up from the average. Brookfield Asset Management Inc. (NYSE:BAM) has risen 13.98% since February 17, 2017 and is uptrending. It has underperformed by 2.72% the S&P500.

Brookfield Asset Management Inc. is a publicly owned asset management holding company. The company has market cap of $37.97 billion. Through its subsidiaries, the firm invests in the property, power, and infrastructure sectors. It has a 87.57 P/E ratio. The Company’s property business includes owning and managing office properties, developing master planned residential communities, and offering clients bridge and mezzanine lending, alternative assets funds, and financial and advisory services.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>